For citations:
Stolyarevich E.S., Artyukhina L.Yu., Ivanova E.S., Tomilina N.A. USE OF COMBINED THERAPY BY PLASMAPHERESIS, HUMAN INTRAVENOUS IMMUNOGLOBULIN AND RITUXIMAB FOR CHRONIC RENAL ALLOGRAFT REJECTION. Nephrology (Saint-Petersburg). 2016;20(6):67-74. (In Russ.)